Skip to main content
Year archive

Luye Pharma Group Limited — 2020 filings

All 108 regulatory filings released by Luye Pharma Group Limited (2186) in 2020, sourced directly from the official regulator.

108 Filings
2020 Period
2020 filings (108)
Filing Released Lang
ANNOUNCEMENT - INCLUSION OF LIPUSU IN THE NEW CATALOGUE OF NATIONAL REIMBURSEMENT DRUG LIST
Regulatory Filings
2020-12-28 English
VOLUNTARY ANNOUNCEMENT - THIRD PARTIES' INVESTMENTS IN SHANDONG BOAN
Regulatory Filings
2020-12-28 English
VOLUNTARY ANNOUNCEMENT - CLASS 1 NEW CHEMICAL DRUG LY03012 COMPLETED PHASE I CLINICAL TRIAL IN CHINA
Regulatory Filings
2020-12-23 English
VOLUNTARY ANNOUNCEMENT - LY03010 COMMENCED PIVOTAL STUDY IN THE U.S.
Regulatory Filings
2020-12-21 English
VOLUNTARY ANNOUNCEMENT - DENOSUMAB INJECTION (LY01011) COMMENCED PHASE III CLINICAL TRIAL IN CHINA
Regulatory Filings
2020-12-15 English
VOLUNTARY ANNOUNCEMENT - LY03005 COMPLETED PRIMARY ENDPOINT OBSERVATION FOR PHASE III CLINIC TRIAL IN CHINA
Regulatory Filings
2020-12-14 English
Interim Report 2020
Regulatory Filings
2020-12-14 English
EXCHANGE NOTICE - RESUMPTION OF TRADING
Regulatory Filings
2020-12-07 English
FULFILMENT OF ALL RESUMPTION CONDITIONS AND RESUMPTION OF TRADING
Regulatory Filings
2020-12-04 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2020
Regulatory Filings
2020-12-04 English
CHANGE OF COMPANY SECRETARY AND AGENT FOR THE ACCEPTANCE OF SERVICE OF PROCESS AND NOTICES IN HONG KONG
Regulatory Filings
2020-12-01 English
Monthly Return of Equity Issuer on Movements in Securities
Regulatory Filings
2020-12-01 English
ANNOUNCEMENT OF INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 SEPTEMBER 2020
Regulatory Filings
2020-11-27 English
POSITIVE PROFIT ALERT
Regulatory Filings
2020-11-24 English
NOTICE OF BOARD MEETING
Regulatory Filings
2020-11-17 English
QUARTERLY UPDATE ON STATUS OF RESUMPTION
Regulatory Filings
2020-11-04 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2020
Regulatory Filings
2020-11-04 English
Monthly Return of Equity Issuer on Movements in Securities
Regulatory Filings
2020-11-02 English
VOLUNTARY ANNOUNCEMENT - COLLABORATION AND EXCLUSIVE PROMOTION AGREEMENTS IN RELATION TO LY09004 WITH OCUMENSION THERAPEUTICS
Regulatory Filings
2020-10-30 English
VOLUNTARY ANNOUNCEMENT - APPROVAL OF INITIATING CLINICAL TRIAL WITH DENOSUMAB BIOSIMILAR CANDIDATE (LY06006/LY01011) IN EUROPE
Regulatory Filings
2020-10-23 English
TERMINATION OF DISCLOSEABLE TRANSACTION IN RELATION TO THE DISPOSAL
Regulatory Filings
2020-10-21 English
Monthly Return of Equity Issuer on Movements in Securities
Regulatory Filings
2020-10-06 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2020
Regulatory Filings
2020-10-05 English
Interim Report 2020
Regulatory Filings
2020-09-28 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2020
Regulatory Filings
2020-09-04 English
Monthly Return of Equity Issuer on Movements in Securities
Regulatory Filings
2020-09-01 English
VOLUNTARY ANNOUNCEMENT - APPROVAL FOR CLINICAL TRIAL FOR RIVASTIGMINE MULTI-DAY TRANSDERMAL PATCH (LY03013) IN CHINA
Regulatory Filings
2020-09-01 English
VOLUNTARY ANNOUNCEMENT - APPROVAL FOR CLINICAL TRIAL FOR LPM4870108 TABLETS IN CHINA
Regulatory Filings
2020-08-27 English
ANNOUNCEMENT OF INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2020
Regulatory Filings
2020-08-27 English
VOLUNTARY ANNOUNCEMENT - APPROVAL FOR CLINICAL TRIAL FOR LURBINECTEDIN (LY01017) IN CHINA
Regulatory Filings
2020-08-26 English
POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON 21 AUGUST 2020
Regulatory Filings
2020-08-21 English
ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT 2019/20
Regulatory Filings
2020-08-21 English
NOTICE OF BOARD MEETING
Regulatory Filings
2020-08-17 English
DELAY IN PUBLICATION OF THE FIRST QUARTERLY RESULTS AND DESPATCH OF THE FIRST QUARTERLY REPORT FOR THE THREE MONTHS ENDED 30 JUNE 2020
Regulatory Filings
2020-08-14 English
DISCLOSEABLE TRANSACTION DISPOSAL OF THE ENTIRE ISSUED SHARE CAPITAL OF TAKSON SPORTSWEAR LIMITED
Regulatory Filings
2020-08-05 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2020
Regulatory Filings
2020-08-04 English
Monthly Return of Equity Issuer on Movements in Securities
Regulatory Filings
2020-08-03 English
QUARTERLY UPDATE ON STATUS OF RESUMPTION
Regulatory Filings
2020-07-31 English
Environmental, Social and Governance Report 2019
Regulatory Filings
2020-07-23 English
ANNOUNCEMENT - FURTHER INFORMATION ON THE DESPATCH OF DIVIDEND WARRANTS
Regulatory Filings
2020-07-22 English
NOTICE OF ANNUAL GENERAL MEETING
Regulatory Filings
2020-07-17 English
Form of proxy for use by shareholders at the Annual General Meeting to be convened on 21 August 2020 at 10:00 a.m.
Regulatory Filings
2020-07-17 English
GENERAL MANDATES TO ISSUE SHARES AND REPURCHASE SHARES&#x3b; RE-ELECTION OF DIRECTORS&#x3b; AND NOTICE OF ANNUAL GENERAL MEETING
Regulatory Filings
2020-07-17 English
Annual Report 2019/20
Regulatory Filings
2020-07-17 English
The Listing Committee censures State Energy Group International Assets Holdings Limited ("Company") (Stock Code: 918) and Mr Zhou Xin Yu, former executive director and CEO of the Company, fo
Regulatory Filings
2020-07-08 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2020
Regulatory Filings
2020-07-03 English
Monthly Return of Equity Issuer on Movements in Securities
Regulatory Filings
2020-07-02 English
ADJUSTMENT TO CONVERSION PRICE OF THE U.S.$300,000,000 1.50 PER CENT. CONVERTIBLE BONDS DUE 2024
Regulatory Filings
2020-06-29 English
VOLUNTARY ANNOUNCEMENT - CLINICAL TRIAL APPLICATION OF LURBINECTEDIN HAS BEEN FORMALLY ACCEPTED BY CDE
Regulatory Filings
2020-06-29 English
Next Day Disclosure Return
Regulatory Filings
2020-06-24 English
POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON 23 JUNE 2020
Regulatory Filings
2020-06-23 English
VOLUNTARY ANNOUNCEMENT - CLINICAL TRIAL APPLICATION OF LPM4870108 TABLETS HAS BEEN FORMALLY ACCEPTED BY CDE
Regulatory Filings
2020-06-23 English
VOLUNTARY ANNOUNCEMENT - THE IND APPLICATION OF RIVASTIGMINE MULTI-DAY TRANSDERMAL PATCH (LY03013) HAS BEEN ACCEPTED BY CDE IN CHINA
Regulatory Filings
2020-06-18 English
CLINICAL TRIAL APPLICATION OF HYDROCHLORIDE IRINOTECAN FLOXURUDINE LIPOSOME INJECTION (LY01616) WAS FORMALLY ACCEPTED BY CDE
Regulatory Filings
2020-06-11 English
VOLUNTARY ANNOUNCEMENT - APPROVAL FOR INITIATING CLINICAL TRIAL FOR DENOSUMAB INJECTION (LY06006/LY01011) IN THE UNITED STATES
Regulatory Filings
2020-06-09 English
UPDATE ON STATUS OF RESUMPTION
Regulatory Filings
2020-06-08 English
VOLUNTARY ANNOUNCEMENT - MARKETING REGISTRATION OF RIVASTIGMINE TRANSDERMAL PATCH APPROVED BY NMPA
Regulatory Filings
2020-06-05 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2020
Regulatory Filings
2020-06-04 English
Monthly Return of Equity Issuer on Movements in Securities
Regulatory Filings
2020-06-01 English
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 MARCH 2020
Regulatory Filings
2020-05-25 English
FORM OF PROXY FOR USE AT ANNUAL GENERAL MEETING TO BE HELD ON 23 JUNE 2020
Regulatory Filings
2020-05-21 English
NOTICE OF ANNUAL GENERAL MEETING
Regulatory Filings
2020-05-21 English
PROPOSALS FOR GENERAL MANDATES TO ISSUE SHARES AND REPURCHASE SHARES AND RE-ELECTION OF RETIRING DIRECTORS AND NOTICE OF ANNUAL GENERAL MEETING
Regulatory Filings
2020-05-21 English
POSITIVE PROFIT ALERT
Regulatory Filings
2020-05-20 English
VOLUNTARY ANNOUNCEMENT - LUYE GRANTED EXCLUSIVE DISTRIBUTION AND MARKETING RIGHTS IN SOUTH KOREA FOR SEROQUEL AND SEROQUEL XR TO ALVOGEN
Regulatory Filings
2020-05-20 English
VOLUNTARY ANNOUNCEMENT - THE MAA FOR RIVALIF (LY30410) IS UNDER REVIEW AT EU COMPETENT AUTHORITIES
Regulatory Filings
2020-05-18 English
VOLUNTARY ANNOUNCEMENT - LUYE GRANTED MOKSHA8 THE EXCLUSIVE PROMOTION RIGHTS IN BRAZIL AND MEXICO FOR SEROQUEL
Regulatory Filings
2020-05-13 English
DATE OF BOARD MEETING
Regulatory Filings
2020-05-12 English
VOLUNTARY ANNOUNCEMENT - SUBMITTED IND APPLICATION IN THE U.S. FOR DENOSUMAB INJECTION (LY06006/LY01011)
Regulatory Filings
2020-05-08 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2020
Regulatory Filings
2020-05-07 English
QUARTERLY UPDATE ON STATUS OF RESUMPTION
Regulatory Filings
2020-05-05 English
Monthly Return of Equity Issuer on Movements in Securities
Regulatory Filings
2020-05-04 English
QUARTERLY UPDATE ON STATUS OF RESUMPTION
Regulatory Filings
2020-04-29 English
Annual Report 2019
Regulatory Filings
2020-04-27 English
VOLUNTARY ANNOUNCEMENT - LIPUSU RECOMMENDED BY CSCO GUIDELINES ON DIAGNOSIS AND TREATMENT OF BREAST CANCER AS THE FIRST-LINE CHEMOTHERAPY
Regulatory Filings
2020-04-22 English
VOLUNTARY ANNOUNCEMENT - MARKETING AUTHORIZATION APPLICATION FOR BEVACIZUMAB INJECTION (LY01008) ACCEPTED IN CHINA
Regulatory Filings
2020-04-16 English
Next Day Disclosure Return
Regulatory Filings
2020-04-16 English
Next Day Disclosure Return
Regulatory Filings
2020-04-06 English
Monthly Return of Equity Issuer on Movements in Securities
Regulatory Filings
2020-04-03 English
Next Day Disclosure Return
Regulatory Filings
2020-04-02 English
Next Day Disclosure Return
Regulatory Filings
2020-04-01 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2020
Regulatory Filings
2020-04-01 English
(Revised) Next Day Disclosure Return
Regulatory Filings
2020-03-31 English
Next Day Disclosure Return
Regulatory Filings
2020-03-31 English
VOLUNTARY ANNOUNCEMENT- APPROVAL FOR CLINICAL TRIAL FOR LY03014 IN CHINA
Regulatory Filings
2020-03-31 English
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER 2019
Regulatory Filings
2020-03-26 English
NOTICE OF BOARD MEETING
Regulatory Filings
2020-03-13 English
VOLUNTARY ANNOUNCEMENT - CLINICAL TRIAL APPLICATION OF LY03014 WAS FORMALLY ACCEPTED BY CDE
Regulatory Filings
2020-03-09 English
VOLUNTARY ANNOUNCEMENT - U.S. FDA ACCEPTED LY03005 NDA FILING
Regulatory Filings
2020-03-04 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 29 February 2020
Regulatory Filings
2020-03-03 English
Monthly Return of Equity Issuer on Movements in Securities
Regulatory Filings
2020-03-03 English
Next Day Disclosure Return
Regulatory Filings
2020-02-21 English
Next Day Disclosure Return
Regulatory Filings
2020-02-18 English
COMPLETION OF DISCLOSEABLE AND CONNECTED TRANSACTION IN RELATION TO THE ACQUISITION OF EQUITY INTEREST IN SHANDONG BOAN
Regulatory Filings
2020-02-17 English
VOLUNTARY ANNOUNCEMENT - LUYE GRANTED CIPLA MEDPRO THE EXCLUSIVE DISTRIBUTION AND MARKETING RIGHTS IN SOUTH AFRICA AND CERTAIN NEIGHBORING COUNTRIES FOR SEROQUEL
Regulatory Filings
2020-02-10 English
VOLUNTARY ANNOUNCEMENT - PROPOSED REPURCHASE OF SHARES
Regulatory Filings
2020-02-04 English
Next Day Disclosure Return
Regulatory Filings
2020-02-03 English
Monthly Return of Equity Issuer on Movements in Securities
Regulatory Filings
2020-02-03 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2020
Regulatory Filings
2020-02-03 English
QUARTERLY UPDATE ON STATUS OF RESUMPTION
Regulatory Filings
2020-01-31 English
VOLUNTARY ANNOUNCEMENT - LUYE PHARMA RECEIVED A COMPLETE RESPONSE LETTER FROM THE U.S. FDA REGARDING ITS NDA FOR LY03004
Regulatory Filings
2020-01-31 English
POLL RESULTS OF THE SPECIAL GENERAL MEETING HELD ON 22 JANUARY 2020
Regulatory Filings
2020-01-22 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2019
Regulatory Filings
2020-01-07 English
PROXY FORM FOR SPECIAL GENERAL MEETING
Regulatory Filings
2020-01-05 English
NOTICE OF THE SPECIAL GENERAL MEETING
Regulatory Filings
2020-01-05 English
DISCLOSEABLE AND CONNECTED TRANSACTION IN RELATION TO THE ACQUISITION OF EQUITY INTEREST IN SHANDONG BOAN AND NOTICE OF SPECIAL GENERAL MEETING
Regulatory Filings
2020-01-05 English
CLOSURE OF REGISTER OF MEMBERS FOR SPECIAL GENERAL MEETING
Regulatory Filings
2020-01-03 English
Monthly Return of Equity Issuer on Movements in Securities
Regulatory Filings
2020-01-02 English